Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Total Current Liabilities (2019 - 2025)

Korro Bio's Total Current Liabilities history spans 7 years, with the latest figure at $11.9 million for Q4 2025.

  • For the quarter ending Q4 2025, Total Current Liabilities fell 20.21% year-over-year to $11.9 million, compared with a TTM value of $11.9 million through Dec 2025, down 20.21%, and an annual FY2025 reading of $11.9 million, down 20.21% over the prior year.
  • Total Current Liabilities for Q4 2025 was $11.9 million at Korro Bio, down from $14.6 million in the prior quarter.
  • The five-year high for Total Current Liabilities was $22.0 million in Q1 2023, with the low at $8.3 million in Q2 2023.
  • Average Total Current Liabilities over 5 years is $13.8 million, with a median of $12.6 million recorded in 2024.
  • Year-over-year, Total Current Liabilities plummeted 78.06% in 2021 and then skyrocketed 123.92% in 2023.
  • Tracing KRRO's Total Current Liabilities over 5 years: stood at $11.4 million in 2021, then dropped by 23.87% to $8.7 million in 2022, then skyrocketed by 123.92% to $19.5 million in 2023, then decreased by 23.22% to $15.0 million in 2024, then dropped by 20.21% to $11.9 million in 2025.
  • Per Business Quant, the three most recent readings for KRRO's Total Current Liabilities are $11.9 million (Q4 2025), $14.6 million (Q3 2025), and $17.2 million (Q2 2025).